Skip to main content
. 2016 Nov 29;8(2):3226–3236. doi: 10.18632/oncotarget.13698

Figure 3. antagomiR-25 exacerbates Dex damages in human osteoblastic cells.

Figure 3

Expressions of miR-25-5p (A, left), PKCζ mRNA (A, right), and listed proteins B. in stable osteoblastic OB-6 cells with antagomiR-25 or non-sense control microRNA (“miR-C”) were shown; Above cells were treated with or without Dex (1 μM) for 24 hours, cell viability (MTT assay, C.) and apoptosis (Histone DNA ELISA assay, D.) were tested. Experiments in this figure were repeated three times, and similar results were obtained. “Ctrl” stands for untreated control group. “Trans” stands for transfection reagents only. *p<0.05 vs. “miR-C” cells.